MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, D. B.
Right arrow Articles by Akabas, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. B.
Right arrow Articles by Akabas, M. H.

Vol. 58, Issue 5, 1129-1136, November 2000

Benzodiazepines Induce a Conformational Change in the Region of the gamma -Aminobutyric Acid Type A Receptor alpha 1-Subunit M3 Membrane-Spanning Segment

Daniel B. Williams and Myles H. Akabas

Integrated Program in Cellular, Molecular and Biophysical Studies, Columbia University College of Physicians and Surgeons, New York, New York (D.B.W.), and the Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York (M.H.A.)

Benzodiazepine binding to gamma -aminobutyric acid type A (GABAA) receptors allosterically modulates GABA binding and increases the currents induced by submaximal GABA concentrations. Benzodiazepines induce conformational changes in the GABA-binding site in the extracellular domain, but it is uncertain whether these conformational changes extend into the membrane-spanning domain where the channel gate is located. Alone, benzodiazepines do not open the channel. We used the substituted-cysteine-accessibility method to investigate diazepam-induced conformational changes in the region of the alpha 1-subunit M3 membrane-spanning segment. In the absence of diazepam or GABA, pCMBS- did not react at a measurable rate with cysteine-substitution mutants between alpha 1Phe296 and alpha 1Glu303. In the presence of 100 nM diazepam, pCMBS- reacted with alpha 1F296C, alpha 1F298C, and alpha 1L301C but not with the other cysteine mutants between alpha 1Phe296 and alpha 1Glu303. These three mutants are a subset of the five residues that we previously showed reacted with pCMBS- applied in the presence of GABA. The pCMBS- reaction rates with these three cysteine mutants were similar in the presence of diazepam and GABA. Thus, diazepam, which binds to the extracellular domain, induces a conformational change in the membrane-spanning domain that is similar to a portion of the change induced by GABA. Because diazepam does not open the channel, these results provide structural evidence that the diazepam-bound state represents an intermediate conformation distinct from the open and resting/closed states of the receptor. The diazepam-induced conformational change in the M3 segment vicinity may be related to the mechanism of allosteric potentiation.


Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. M. Hanson and C. Czajkowski
Structural Mechanisms Underlying Benzodiazepine Modulation of the GABAA Receptor
J. Neurosci., March 26, 2008; 28(13): 3490 - 3499.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
M. Bali and M. H. Akabas
The Location of a Closed Channel Gate in the GABAA Receptor Channel
J. Gen. Physiol., January 29, 2007; 129(2): 145 - 159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Luu, P. W. Gage, and M. L. Tierney
GABA Increases both the Conductance and Mean Open Time of Recombinant GABAA Channels Co-expressed with GABARAP
J. Biol. Chem., November 24, 2006; 281(47): 35699 - 35708.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. M. Jones-Davis, L. Song, M. J. Gallagher, and R. L. Macdonald
Structural Determinants of Benzodiazepine Allosteric Regulation of GABAA Receptor Currents
J. Neurosci., August 31, 2005; 25(35): 8056 - 8065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Jung, M. H. Akabas, and R. A. Harris
Functional and Structural Analysis of the GABAA Receptor {alpha}1 Subunit during Channel Gating and Alcohol Modulation
J. Biol. Chem., January 7, 2005; 280(1): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. A. Lobo, M. P. Mascia, J. R. Trudell, and R. A. Harris
Channel Gating of the Glycine Receptor Changes Accessibility to Residues Implicated in Receptor Potentiation by Alcohols and Anesthetics
J. Biol. Chem., August 6, 2004; 279(32): 33919 - 33927.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. J. Gallagher, L. Song, F. Arain, and R. L. Macdonald
The Juvenile Myoclonic Epilepsy GABAA Receptor {alpha}1 Subunit Mutation A322D Produces Asymmetrical, Subunit Position-Dependent Reduction of Heterozygous Receptor Currents and {alpha}1 Subunit Protein Expression
J. Neurosci., June 16, 2004; 24(24): 5570 - 5578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Cascio
Structure and Function of the Glycine Receptor and Related Nicotinicoid Receptors
J. Biol. Chem., May 7, 2004; 279(19): 19383 - 19386.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Newell and C. Czajkowski
The GABAA Receptor alpha 1 Subunit Pro174-Asp191 Segment Is Involved in GABA Binding and Channel Gating
J. Biol. Chem., April 4, 2003; 278(15): 13166 - 13172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Bera, M. Chatav, and M. H. Akabas
GABAA Receptor M2-M3 Loop Secondary Structure and Changes in Accessibility during Channel Gating
J. Biol. Chem., November 1, 2002; 277(45): 43002 - 43010.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. B. Williams and M. H. Akabas
Structural Evidence that Propofol Stabilizes Different GABAA Receptor States at Potentiating and Activating Concentrations
J. Neurosci., September 1, 2002; 22(17): 7417 - 7424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Murphy, V. V. Ivanenkov, and T. L. Kirley
Identification of Cysteine Residues Responsible for Oxidative Cross-linking and Chemical Inhibition of Human Nucleoside-triphosphate Diphosphohydrolase 3
J. Biol. Chem., February 15, 2002; 277(8): 6162 - 6169.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. T. Bianchi and R. L. Macdonald
Agonist Trapping by GABAA Receptor Channels
J. Neurosci., December 1, 2001; 21(23): 9083 - 9091.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Teissere and C. Czajkowski
A {beta}-Strand in the {gamma}2 Subunit Lines the Benzodiazepine Binding Site of the GABAA Receptor: Structural Rearrangements Detected during Channel Gating
J. Neurosci., July 15, 2001; 21(14): 4977 - 4986.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. Sigel, R. Baur, R. Furtmueller, R. Razet, R. H. Dodd, and W. Sieghart
Differential Cross Talk of ROD Compounds with the Benzodiazepine Binding Site
Mol. Pharmacol., June 1, 2001; 59(6): 1470 - 1477.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
J. W. Lynch, N.-L. R. Han, J. Haddrill, K. D. Pierce, and P. R. Schofield
The Surface Accessibility of the Glycine Receptor M2-M3 Loop Is Increased in the Channel Open State
J. Neurosci., April 15, 2001; 21(8): 2589 - 2599.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics